成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

Home Cart Sign in  
Chemical Structure| 1033769-28-6 Chemical Structure| 1033769-28-6
Chemical Structure| 1033769-28-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

{[proInfo.proName]}

CAS No.: 1033769-28-6

,{[proInfo.pro_purity]}

GNF-5837 is a potent pan-Trk inhibitor which display antiproliferative effects in cellular Ba/F3 assays (IC50 values are 7, 9 and 11 nM for cells containing the fusion proteins Tel-TrkC, Tel-TrkB and Tel-TrkA, respectively).

Synonyms: GNF-5837

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Alternative Products

Product Details of GNF-5837

CAS No. :1033769-28-6
Formula : C28H21F4N5O2
M.W : 535.49
SMILES Code : O=C(NC1=CC(C(F)(F)F)=CC=C1F)NC2=CC=C(C)C(NC3=CC(NC/4=O)=C(C=C3)C4=C\C5=CC=CN5)=C2
Synonyms :
GNF-5837
MDL No. :MFCD24386809

Safety of GNF-5837

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of GNF-5837

RTK

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description Reference
JIMT-1 0–40 μM 48 hours To evaluate the effect of GNF-5837 on the viability of HER2-positive breast cancer cells, results showed that GNF-5837 reduced cell viability in a dose-dependent manner. PMC7564775
MDA-MB-453 0–40 μM 48 hours To evaluate the effect of GNF-5837 on the viability of HER2-positive breast cancer cells, results showed that GNF-5837 reduced cell viability in a dose-dependent manner. PMC7564775
BT-474 0–40 μM 48 hours To evaluate the effect of GNF-5837 on the viability of HER2-positive breast cancer cells, results showed that GNF-5837 reduced cell viability in a dose-dependent manner. PMC7564775
SK-BR-3 0–40 μM 48 hours To evaluate the effect of GNF-5837 on the viability of HER2-positive breast cancer cells, results showed that GNF-5837 reduced cell viability in a dose-dependent manner. PMC7564775

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description Reference
Mice Wild-type and TRPV1 KO mice Intraplantar injection 500 ng Single administration, observed for 3 hours To investigate the inhibitory effect of GNF-5837 on NGF-induced thermal hyperalgesia. Results showed that pretreatment with GNF-5837 significantly inhibited NGF-induced thermal hyperalgesia. PMC4854968

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.87mL

0.37mL

0.19mL

9.34mL

1.87mL

0.93mL

18.67mL

3.73mL

1.87mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories